Exhibit-10.12
AMENDMENT TO FINANCIAL PRODUCTS LICENSE AGREEMENT
This Amendment is entered into as of October 16, 2026, by and between CF Benchmarks Ltd (“Licensor”), Bitwise
Investment Advisers, LLC, (“BIA”) and Bitwise Investment Manager, LLC (“BIM”) (each, a “Licensee” and
together, the “Licensees”).
The Licensor and BIM entered into a Financial Product License Agreement on July 12th, 2023, as amended by the
Variation Agreement on May 1st, 2024, October 27th, 2025 and December 12, 2025 (the “Original Agreement”).
The Licensor and Licensees, through this amendment agreement (the “Amendment Agreement”), wish to amend the
Original Agreement by adding BIA as a third counterparty and by incorporating the changes set out below.
The amendments and additions contained herein shall have effect from October 15, 2026 onwards, and shall
supersede, where applicable, provisions contained in the Original Agreement.
Except as expressly amended by this Amendment, all terms and conditions of the Original Agreement shall remain
unchanged and in full force and effect. This Amendment shall be read and construed as one with the Original
Agreement, and, in the event of any conflict, the terms of this Amendment shall prevail with respect to the subject
matter herein.
The terms of the Original Agreement shall be deemed amended to reflect both the express changes set forth in this
Amendment Agreement and any other modifications that are reasonably necessary to give full effect to such changes.
Except to the extent inconsistent with this Amendment Agreement or the changes effected hereby, all other terms,
conditions, rights, and obligations of the Original Agreement shall remain unchanged and in full force and effect. This
Amendment Agreement and the Original Agreement shall be read and construed together as a single contract.
Licensor and Licensee are sometimes referred to herein collectively as the “Parties” and individually as a “Party”
WITNESSETH:
WHEREAS, the Licensees wishes to license additional indices from Licensor for use in connection with certain
financial products; and
WHEREAS, the Parties desire to amend Schedule 1 and Schedule 2 inclusive, of the Original Agreement.
REPLACEMENT OF SCHEDULE 1
The Parties agree to amend and replace the existing SCHEDULE 1 of the Original Agreement in its entirety
with the below.
SCHEDULE 1
| Asset Pair | License GrantDate | Indices |
| Bitcoin - US Dollar | January 11th 2024 | CME CF Bitcoin Real Time Index (BRTI) |
| CME CF Bitcoin Reference Rate (BRR) | ||
| CME CF Bitcoin Reference Rate - New York Variant (BRRNY) | ||
| CME CF Bitcoin Reference Rate – APAC Variant (BRRAP) | ||
| Ether -US Dollar | July 23rd 2024 | CME CF Ether - Dollar Real Time Index (ETHUSD_RTI) |
| CME CF Ether - Dollar Reference Rate (ETHUSD_RR) | ||
| CME CF Ether - Dollar Reference Rate - New York Variant(ETHUSD_NY) |
Exhibit-10.12
Exhibit-10.12
| CME CF Ether – Dollar Reference Rate – APAC Variant(ETHUSD_AP) | ||
| Solana - US Dollar | The date at whichProduct Number 4is admitted fortrading on aNational StockExchange | CME CF Solana - Dollar Real Time Index (SOLUSD_RTI) |
| CME CF Solana - Dollar Reference Rate (SOLUSD_RR) | ||
| CME CF Solana - Dollar Reference Rate - New York Variant(SOLUSD_NY) | ||
| CME CF Solana – Dollar Reference Rate – APAC Variant(SOLUSD_AP) | ||
| Chainlink - US Dollar | The date at whichProduct Number 5is admitted fortrading on aNational StockExchange | CME CF Chainlink - Dollar Real Time Index (LINKUSD_RTI) |
| CME CF Chainlink - Dollar Reference Rate (LINKUSD_RR) | ||
| CME CF Chainlink - Dollar Reference Rate - New York Variant(LINKUSD_NY) | ||
| CME CF Chainlink – Dollar Reference Rate – APAC Variant(LINKUSD_AP) | ||
| DOGE - US Dollar | The date at whichProduct Number 6is admitted fortrading on aNational StockExchange | CF DOGE - Dollar Real Time Index (DOGEUSD_RTI) |
| CF DOGE - Dollar Reference Rate (DOGEUSD_RR) | ||
| CF DOGE - Dollar Reference Rate - New York Variant(DOGEUSD_NY) | ||
| CF DOGE – Dollar Reference Rate – APAC Variant(DOGEUSD_AP) | ||
| Avalanche - US Dollar | The date at whichProduct Number 7is admitted fortrading on aNational StockExchange | CME CF Avalanche - Dollar Real Time Index(AVAXUSD_RTI) |
| CME CF Avalanche - Dollar Reference Rate (AVAXUSD_RR) | ||
| CME CF Avalanche - Dollar Reference Rate - New YorkVariant (AVAXUSD_NY) | ||
| CME CF Avalanche – Dollar Reference Rate – APAC Variant(AVAXUSD_AP) | ||
| XRP - US Dollar | The date at whichProduct Number 8is admitted fortrading on aNational StockExchange | CME CF XRP - Dollar Real Time Index (XRPUSD_RTI) |
| CME CF XRP - Dollar Reference Rate (XRPUSD_RR) | ||
| CME CF XRP - Dollar Reference Rate - New York Variant(XRPUSD_NY) | ||
| CME CF XRP – Dollar Reference Rate – APAC Variant(XRPUSD_AP) |
Exhibit-10.12
| HYPE - US Dollar | The date at which | CF HYPE - Dollar Real Time Index (HYPEUSD_RTI) |
Exhibit-10.12
| Product Number 9is admitted fortrading on aNational StockExchange | CF HYPE - Dollar Reference Rate - New York Variant(HYPEUSD_NY) | |
| CF HYPE - Dollar Reference Rate (HYPEUSD_RR) | ||
| CF HYPE - Dollar Reference Rate - APAC Variant(HYPEUSD_AP) | ||
| NEAR – US Dollar | The date at whichProduct Number10 is admitted fortrading on aNational StockExchange | CME CF NEAR – Dollar Real Time Index (NEARUSD_RTI) |
| CME CF NEAR Protocol-Dollar Reference Rate – New YorkVariant (NEARUSD_NY) | ||
| CME CF NEAR Protocol-Dollar Reference Rate(NEARUSD_RR) | ||
| ZEC - US Dollar | The date at whichProduct Number11 is admitted fortrading on aNational StockExchange | CF ZEC - Dollar Real Time Index (ZECUSD_RTI) |
| CF ZEC - Dollar Reference Rate - New York Variant(ZECUSD_NY) | ||
| CF ZEC - Dollar Reference Rate (ZECUSD_RR) | ||
| CF ZEC - Dollar Reference Rate - APAC Variant(ZECUSD_AP) |
In addition to the above indices, CF Benchmarks will also provide the Free Float Supply of each base asset
listed in the above table, which the Licensees may utilise for the defined use cases in connection with the
Products listed in Schedule 2.
Exhibit-10.12
REPLACEMENT OF SCHEDULE 2
The Parties further agree to amend and replace the existing SCHEDULE 2 of the Original Agreement in its
entirety with the below SCHEDULE 2.
SCHEDULE 2 – SPECIFIED PRODUCTS & USES CASES
| Number | FINANCIALPRODUCTS | USE CASES |
| 1 | The Bitwise BitcoinETF (BITB) anExchange TradedFund to admittedfor trading onCBOE BZX and/orother NationalStock Exchanges | ● The calculation of Net Asset Value (NAV) or Indicative Net Asset Value(I-NAV) for the Product in the course of administering, reporting andmarketing the Product● The determination of the Product AuM in the course of administering,reporting and marketing the Product● The dissemination of the Product NAV, I-NAV and AuM in the Productthat have been calculated using the Index Data● Comparing the Index Data to data associated with the Nominated Productin its Informational Materials, such as performance, returns, volatility,drawdown, Sharpe ratio and other commonly used financial andinvestment metrics |
| 2 | The BitwiseEthereum ETF(ETHW), ExchangeTraded Fund toadmitted for tradingon CBOE BZXand/or otherNational StockExchanges | ● The calculation of Net Asset Value (NAV) or Indicative Net Asset Value(I-NAV) for the Product in the course of administering, reporting andmarketing the Product● The determination of the Product AuM in the course of administering,reporting and marketing the Product● The dissemination of the Product NAV, I-NAV and AuM in the Productthat have been calculated using the Index Data● Comparing the Index Data to data associated with the Nominated Productin its Informational Materials, such as performance, returns, volatility,drawdown, Sharpe ratio and other commonly used financial andinvestment metrics |
| 3 | The Bitwise Bitcoin& Ethereum ETF,Exchange TradedFund to admittedfor trading onCBOE BZX and/orother NationalStock Exchanges | ● The calculation of Net Asset Value (NAV) or Indicative Net Asset Value(I-NAV) for the Product in the course of administering, reporting andmarketing the Product● The determination of the Product AuM in the course of administering,reporting and marketing the Product● The dissemination of the Product NAV, I-NAV and AuM in the Productthat have been calculated using the Index Data● Comparing the Index Data to data associated with the Nominated Productin its Informational Materials, such as performance, returns, volatility,drawdown, Sharpe ratio and other commonly used financial andinvestment metrics● Utilisation of Free Float Data as listed in Schedule 1 in order to determinethe weights of each base asset within the Product |
Exhibit-10.12
| 4 | The Bitwise SolanaETF, ExchangeTraded Fund toadmitted for tradingon CBOE BZXand/or otherNational StockExchanges | ● The calculation of Net Asset Value (NAV) or Indicative Net Asset Value(I-NAV) for the Product in the course of administering, reporting andmarketing the Product● The determination of the Product AuM in the course of administering,reporting and marketing the Product● The dissemination of the Product NAV, I-NAV and AuM in the Productthat have been calculated using the Index Data● Comparing the Index Data to data associated with the Nominated Productin its Informational Materials, such as performance, returns, volatility,drawdown, Sharpe ratio and other commonly used financial andinvestment metrics● Utilisation of Free Float Data as listed in Schedule 1 in order to determinethe weights of each base asset within the Product |
| 5 | The BitwiseChainlink ETF,Exchange TradedFund to admittedfor trading onCBOE BZX and/orother NationalStock Exchanges | ● The calculation of Net Asset Value (NAV) or Indicative Net Asset Value(I-NAV) for the Product in the course of administering, reporting andmarketing the Product● The determination of the Product AuM in the course of administering,reporting and marketing the Product● The dissemination of the Product NAV, I-NAV and AuM in the Productthat have been calculated using the Index Data● Comparing the Index Data to data associated with the Nominated Productin its Informational Materials, such as performance, returns, volatility,drawdown, Sharpe ratio and other commonly used financial andinvestment metrics● Utilisation of Free Float Data as listed in Schedule 1 in order to determinethe weights of each base asset within the Product |
| 6 | The Bitwise DOGEETF, ExchangeTraded Fund toadmitted for tradingon CBOE BZXand/or otherNational StockExchanges | ● The calculation of Net Asset Value (NAV) or Indicative Net Asset Value(I-NAV) for the Product in the course of administering, reporting andmarketing the Product● The determination of the Product AuM in the course of administering,reporting and marketing the Product● The dissemination of the Product NAV, I-NAV and AuM in the Productthat have been calculated using the Index Data● Comparing the Index Data to data associated with the Nominated Productin its Informational Materials, such as performance, returns, volatility,drawdown, Sharpe ratio and other commonly used financial andinvestment metrics● Utilisation of Free Float Data as listed in Schedule 1 in order to determinethe weights of each base asset within the Product |
Exhibit-10.12
| 7 | The BitwiseAvalanche ETF,Exchange TradedFund to admittedfor trading onCBOE BZX and/orother NationalStock Exchanges | ● The calculation of Net Asset Value (NAV) or Indicative Net Asset Value(I-NAV) for the Product in the course of administering, reporting andmarketing the Product● The determination of the Product AuM in the course of administering,reporting and marketing the Product● The dissemination of the Product NAV, I-NAV and AuM in the Productthat have been calculated using the Index Data● Comparing the Index Data to data associated with the Nominated Productin its Informational Materials, such as performance, returns, volatility,drawdown, Sharpe ratio and other commonly used financial andinvestment metrics● Utilisation of Free Float Data as listed in Schedule 1 in order to determinethe weights of each base asset within the Product |
| 8 | The Bitwise XRPETF, ExchangeTraded Fund toadmitted for tradingon CBOE BZXand/or otherNational StockExchanges | ● The calculation of Net Asset Value (NAV) or Indicative Net Asset Value(I-NAV) for the Product in the course of administering, reporting andmarketing the Product● The determination of the Product AuM in the course of administering,reporting and marketing the Product● The dissemination of the Product NAV, I-NAV and AuM in the Productthat have been calculated using the Index Data● Comparing the Index Data to data associated with the Nominated Productin its Informational Materials, such as performance, returns, volatility,drawdown, Sharpe ratio and other commonly used financial andinvestment metrics● Utilisation of Free Float Data as listed in Schedule 1 in order to determinethe weights of each base asset within the Product |
| 9 | The Bitwise HYPEETF, ExchangeTraded Fund toadmitted for tradingon CBOE BZXand/or otherNational StockExchanges | ● The calculation of Net Asset Value (NAV) or Indicative Net Asset Value(I-NAV) for the Product in the course of administering, reporting andmarketing the Product● The determination of the Product AuM in the course of administering,reporting and marketing the Product● The dissemination of the Product NAV, I-NAV and AuM in the Productthat have been calculated using the Index Data● Comparing the Index Data to data associated with the Nominated Productin its Informational Materials, such as performance, returns, volatility,drawdown, Sharpe ratio and other commonly used financial andinvestment metrics● Utilisation of Free Float Data as listed in Schedule 1 in order to determinethe weights of each base asset within the Product |
Exhibit-10.12
| 10 | The Bitwise NEARETF, Exchange TradedFund to admitted fortrading on CBOE BZXand/or other NationalStock Exchanges | ● The calculation of Net Asset Value (NAV) or Indicative Net Asset Value(I-NAV) for the Product in the course of administering, reporting andmarketing the Product● The determination of the Product AuM in the course of administering,reporting and marketing the Product● The dissemination of the Product NAV, I-NAV and AuM in the Productthat have been calculated using the Index Data● Comparing the Index Data to data associated with the Nominated Productin its Informational Materials, such as performance, returns, volatility,drawdown, Sharpe ratio and other commonly used financial andinvestment metrics● Utilisation of Free Float Data as listed in Schedule 1 in order to determinethe weights of each base asset within the Product |
| 11 | The Bitwise ZECETF, ExchangeTraded Fund toadmitted for tradingon CBOE BZXand/or otherNational StockExchanges | ● The calculation of Net Asset Value (NAV) or Indicative Net Asset Value(I-NAV) for the Product in the course of administering, reporting andmarketing the Product● The determination of the Product AuM in the course of administering,reporting and marketing the Product● The dissemination of the Product NAV, I-NAV and AuM in the Productthat have been calculated using the Index Data● Comparing the Index Data to data associated with the Nominated Productin its Informational Materials, such as performance, returns, volatility,drawdown, Sharpe ratio and other commonly used financial andinvestment metrics● Utilisation of Free Float Data as listed in Schedule 1 in order to determinethe weights of each base asset within the Product |
Exhibit-10.12
| Signed by Johanna Collins-Wood for and on behalf of BITWISEINVESTMENT MANAGER, LLC | By: /s/ Johanna Collins-WoodAuthorised Signatory |
| Signed by Sui Chung for and on behalf of CF BENCHMARKS LTD | By: /s/ Sui ChungDirector |